JP2024531338A5 - - Google Patents

Info

Publication number
JP2024531338A5
JP2024531338A5 JP2024509376A JP2024509376A JP2024531338A5 JP 2024531338 A5 JP2024531338 A5 JP 2024531338A5 JP 2024509376 A JP2024509376 A JP 2024509376A JP 2024509376 A JP2024509376 A JP 2024509376A JP 2024531338 A5 JP2024531338 A5 JP 2024531338A5
Authority
JP
Japan
Application number
JP2024509376A
Other languages
Japanese (ja)
Other versions
JP2024531338A (ja
JPWO2023023131A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/040564 external-priority patent/WO2023023131A2/en
Publication of JP2024531338A publication Critical patent/JP2024531338A/ja
Publication of JP2024531338A5 publication Critical patent/JP2024531338A5/ja
Publication of JPWO2023023131A5 publication Critical patent/JPWO2023023131A5/ja
Pending legal-status Critical Current

Links

JP2024509376A 2021-08-18 2022-08-17 活性化可能インターフェロンポリペプチド及びその使用方法 Pending JP2024531338A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163234284P 2021-08-18 2021-08-18
US63/234,284 2021-08-18
PCT/US2022/040564 WO2023023131A2 (en) 2021-08-18 2022-08-17 Activatable inteferon polypeptides and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2024531338A JP2024531338A (ja) 2024-08-29
JP2024531338A5 true JP2024531338A5 (https=) 2025-08-25
JPWO2023023131A5 JPWO2023023131A5 (https=) 2025-08-25

Family

ID=83899708

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024509376A Pending JP2024531338A (ja) 2021-08-18 2022-08-17 活性化可能インターフェロンポリペプチド及びその使用方法

Country Status (7)

Country Link
US (1) US20240216474A1 (https=)
EP (1) EP4387987A2 (https=)
JP (1) JP2024531338A (https=)
CN (1) CN118119634A (https=)
CA (1) CA3228927A1 (https=)
TW (1) TW202321284A (https=)
WO (1) WO2023023131A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021231773A1 (en) 2020-05-13 2021-11-18 Good Therapeutics, Inc. Compositions of protein complexes and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006110728A2 (en) 2005-04-12 2006-10-19 The Uab Research Foundation Immunogenic cmv tegument aggregates
JP5861223B2 (ja) * 2009-02-23 2016-02-16 サイトムエックス セラピューティクス, インク.CytomX Therapeutics, Inc. プロタンパク質およびその使用方法
CN111050803A (zh) * 2017-06-20 2020-04-21 德克萨斯大学系统董事会 用于治疗癌症的干扰素前药
US20210130430A1 (en) * 2018-05-14 2021-05-06 Werewolf Therapeutics, Inc. Activatable cytokine polypeptides and methods of use thereof
CN120463822A (zh) * 2018-09-27 2025-08-12 西里欧发展公司 掩蔽型细胞因子多肽
BR112022009110A2 (pt) * 2019-11-14 2022-07-26 Werewolf Therapeutics Inc Polipeptídeos de citocina ativáveis e métodos de uso destes
US20210252142A1 (en) * 2020-02-06 2021-08-19 Aetio Biotherapy, Inc. Compositions and methods for treating viral infections

Similar Documents

Publication Publication Date Title
JP2024538707A5 (https=)
JP2024531338A5 (https=)
CL2025002729A1 (es) Válvulas de sifón neumáticas y cámaras de reacción para el análisis de muestras
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BY13172U (https=)
BY13167U (https=)
CN307049947S (https=)
CN307049373S (https=)
CN307048433S (https=)
CN307048222S (https=)
CN307047724S (https=)
CN307047685S (https=)
CN307047155S (https=)
CN307045891S (https=)
CN307045696S (https=)
CN307045430S (https=)
CN307044800S (https=)
CN307044748S (https=)
CN307044266S (https=)
BY23963C1 (https=)
BY13176U (https=)
BY13175U (https=)
BY13170U (https=)